Medios AG (ETR:ILM1)
Germany flag Germany · Delayed Price · Currency is EUR
13.68
+0.08 (0.59%)
Apr 29, 2026, 5:35 PM CET

Medios AG Company Description

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany.

It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply.

The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies.

This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions.

The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service.

The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases.

Medios AG is founded in 2015 and was headquartered in Berlin, Germany.

Medios AG
Medios AG logo
Country Germany
Founded 2016
Industry Medical Distribution
Sector Healthcare
Employees 868
CEO Thomas Meier

Contact Details

Address:
Heidestrasse 9
Berlin, 10557
Germany
Phone 49 30 232 5668 00
Website medios.ag

Stock Details

Ticker Symbol ILM1
Exchange Deutsche Börse Xetra
Fiscal Year January - December
Reporting Currency EUR
ISIN Number DE000A1MMCC8
SIC Code 5122

Key Executives

Name Position
Thomas Meier Chief Executive Officer and Member of Executive Board